The role of TGFβ as a tumor suppressor is substantiated by previous work identifying epithelial loss of SMAD4, indicative of disrupted TGFβ signaling, in the progression of sporadic microsatellite stable advanced colorectal tumors [5]. The gene discussed is TGFB1; the disease is colorectal neoplasm.